Frequency of Subgroups of Birth Defects Diagnosed Before 2 Years of Age in the Extended NRBC Cohort of Children Born in 1997–2016 According to Maternal Use of ATDs in Early Pregnancy
. | Nonexposeda . | MMI . | PTU . | |||||
---|---|---|---|---|---|---|---|---|
. | n = 1,159,181 . | n = 1574 . | n = 889 . | |||||
. | n . | % . | nb . | % . | Pc . | nb . | % . | Pc . |
Subgroups of birth defects (Q00–99) | ||||||||
Nervous system (Q00–07) | 1180 | 0.10 | <3 | <0.3 | 0.6 | <3 | <0.3 | 0.9 |
Eye (Q10–15) | 2480 | 0.21 | 7 | 0.44 | 0.05 | 0 | 0.00 | 0.2 |
Ear (Q16–17) | 773 | 0.07 | <3 | <0.3 | 0.4 | <3 | <0.3 | 0.07 |
Face and neck, others (Q18) | 907 | 0.08 | 0 | 0.00 | 0.3 | 3 | 0.34 | 0.006 |
Circulatory system (Q20–28) | 15,195 | 1.31 | 39 | 2.48 | <0.001 | 16 | 1.80 | 0.2 |
Respiratory system (Q30–38) | 9636 | 0.83 | 23 | 1.46 | 0.006 | 12 | 1.35 | 0.09 |
Digestive system (Q39–45) | 3251 | 0.28 | 16 | 1.02 | <0.001 | <3 | <0.3 | 0.8 |
Genital organs (Q50–56) | 12,182 | 1.05 | 15 | 0.95 | 0.7 | 9 | 1.01 | 0.9 |
Urinary system (Q60–64) | 4125 | 0.36 | 12 | 0.76 | 0.007 | 7 | 0.79 | 0.03 |
Musculoskeletal system (Q65–78) | 29,260 | 2.52 | 34 | 2.16 | 0.4 | 26 | 2.92 | 0.4 |
Musculoskeletal system, others (Q79) | 925 | 0.08 | 7 | 0.44 | <0.001 | 0 | 0.00 | 0.4 |
Integumentary system (Q80–84) | 2002 | 0.17 | 11 | 0.70 | <0.001 | <3 | <0.3 | 0.7 |
Others (Q85–99) | 5532 | 0.48 | 9 | 0.57 | 0.6 | 4 | 0.45 | 0.9 |
. | Nonexposeda . | MMI . | PTU . | |||||
---|---|---|---|---|---|---|---|---|
. | n = 1,159,181 . | n = 1574 . | n = 889 . | |||||
. | n . | % . | nb . | % . | Pc . | nb . | % . | Pc . |
Subgroups of birth defects (Q00–99) | ||||||||
Nervous system (Q00–07) | 1180 | 0.10 | <3 | <0.3 | 0.6 | <3 | <0.3 | 0.9 |
Eye (Q10–15) | 2480 | 0.21 | 7 | 0.44 | 0.05 | 0 | 0.00 | 0.2 |
Ear (Q16–17) | 773 | 0.07 | <3 | <0.3 | 0.4 | <3 | <0.3 | 0.07 |
Face and neck, others (Q18) | 907 | 0.08 | 0 | 0.00 | 0.3 | 3 | 0.34 | 0.006 |
Circulatory system (Q20–28) | 15,195 | 1.31 | 39 | 2.48 | <0.001 | 16 | 1.80 | 0.2 |
Respiratory system (Q30–38) | 9636 | 0.83 | 23 | 1.46 | 0.006 | 12 | 1.35 | 0.09 |
Digestive system (Q39–45) | 3251 | 0.28 | 16 | 1.02 | <0.001 | <3 | <0.3 | 0.8 |
Genital organs (Q50–56) | 12,182 | 1.05 | 15 | 0.95 | 0.7 | 9 | 1.01 | 0.9 |
Urinary system (Q60–64) | 4125 | 0.36 | 12 | 0.76 | 0.007 | 7 | 0.79 | 0.03 |
Musculoskeletal system (Q65–78) | 29,260 | 2.52 | 34 | 2.16 | 0.4 | 26 | 2.92 | 0.4 |
Musculoskeletal system, others (Q79) | 925 | 0.08 | 7 | 0.44 | <0.001 | 0 | 0.00 | 0.4 |
Integumentary system (Q80–84) | 2002 | 0.17 | 11 | 0.70 | <0.001 | <3 | <0.3 | 0.7 |
Others (Q85–99) | 5532 | 0.48 | 9 | 0.57 | 0.6 | 4 | 0.45 | 0.9 |
No diagnosis of hyperthyroidism, no redeemed prescription of ATDs or levothyroxine, no thyroid surgery 1995–2017.
Subgroups with less than three cases were reported as <3 according to the regulations for the use of register-based data.
P value is the result of comparison with the nonexposed group via χ2 test.
Frequency of Subgroups of Birth Defects Diagnosed Before 2 Years of Age in the Extended NRBC Cohort of Children Born in 1997–2016 According to Maternal Use of ATDs in Early Pregnancy
. | Nonexposeda . | MMI . | PTU . | |||||
---|---|---|---|---|---|---|---|---|
. | n = 1,159,181 . | n = 1574 . | n = 889 . | |||||
. | n . | % . | nb . | % . | Pc . | nb . | % . | Pc . |
Subgroups of birth defects (Q00–99) | ||||||||
Nervous system (Q00–07) | 1180 | 0.10 | <3 | <0.3 | 0.6 | <3 | <0.3 | 0.9 |
Eye (Q10–15) | 2480 | 0.21 | 7 | 0.44 | 0.05 | 0 | 0.00 | 0.2 |
Ear (Q16–17) | 773 | 0.07 | <3 | <0.3 | 0.4 | <3 | <0.3 | 0.07 |
Face and neck, others (Q18) | 907 | 0.08 | 0 | 0.00 | 0.3 | 3 | 0.34 | 0.006 |
Circulatory system (Q20–28) | 15,195 | 1.31 | 39 | 2.48 | <0.001 | 16 | 1.80 | 0.2 |
Respiratory system (Q30–38) | 9636 | 0.83 | 23 | 1.46 | 0.006 | 12 | 1.35 | 0.09 |
Digestive system (Q39–45) | 3251 | 0.28 | 16 | 1.02 | <0.001 | <3 | <0.3 | 0.8 |
Genital organs (Q50–56) | 12,182 | 1.05 | 15 | 0.95 | 0.7 | 9 | 1.01 | 0.9 |
Urinary system (Q60–64) | 4125 | 0.36 | 12 | 0.76 | 0.007 | 7 | 0.79 | 0.03 |
Musculoskeletal system (Q65–78) | 29,260 | 2.52 | 34 | 2.16 | 0.4 | 26 | 2.92 | 0.4 |
Musculoskeletal system, others (Q79) | 925 | 0.08 | 7 | 0.44 | <0.001 | 0 | 0.00 | 0.4 |
Integumentary system (Q80–84) | 2002 | 0.17 | 11 | 0.70 | <0.001 | <3 | <0.3 | 0.7 |
Others (Q85–99) | 5532 | 0.48 | 9 | 0.57 | 0.6 | 4 | 0.45 | 0.9 |
. | Nonexposeda . | MMI . | PTU . | |||||
---|---|---|---|---|---|---|---|---|
. | n = 1,159,181 . | n = 1574 . | n = 889 . | |||||
. | n . | % . | nb . | % . | Pc . | nb . | % . | Pc . |
Subgroups of birth defects (Q00–99) | ||||||||
Nervous system (Q00–07) | 1180 | 0.10 | <3 | <0.3 | 0.6 | <3 | <0.3 | 0.9 |
Eye (Q10–15) | 2480 | 0.21 | 7 | 0.44 | 0.05 | 0 | 0.00 | 0.2 |
Ear (Q16–17) | 773 | 0.07 | <3 | <0.3 | 0.4 | <3 | <0.3 | 0.07 |
Face and neck, others (Q18) | 907 | 0.08 | 0 | 0.00 | 0.3 | 3 | 0.34 | 0.006 |
Circulatory system (Q20–28) | 15,195 | 1.31 | 39 | 2.48 | <0.001 | 16 | 1.80 | 0.2 |
Respiratory system (Q30–38) | 9636 | 0.83 | 23 | 1.46 | 0.006 | 12 | 1.35 | 0.09 |
Digestive system (Q39–45) | 3251 | 0.28 | 16 | 1.02 | <0.001 | <3 | <0.3 | 0.8 |
Genital organs (Q50–56) | 12,182 | 1.05 | 15 | 0.95 | 0.7 | 9 | 1.01 | 0.9 |
Urinary system (Q60–64) | 4125 | 0.36 | 12 | 0.76 | 0.007 | 7 | 0.79 | 0.03 |
Musculoskeletal system (Q65–78) | 29,260 | 2.52 | 34 | 2.16 | 0.4 | 26 | 2.92 | 0.4 |
Musculoskeletal system, others (Q79) | 925 | 0.08 | 7 | 0.44 | <0.001 | 0 | 0.00 | 0.4 |
Integumentary system (Q80–84) | 2002 | 0.17 | 11 | 0.70 | <0.001 | <3 | <0.3 | 0.7 |
Others (Q85–99) | 5532 | 0.48 | 9 | 0.57 | 0.6 | 4 | 0.45 | 0.9 |
No diagnosis of hyperthyroidism, no redeemed prescription of ATDs or levothyroxine, no thyroid surgery 1995–2017.
Subgroups with less than three cases were reported as <3 according to the regulations for the use of register-based data.
P value is the result of comparison with the nonexposed group via χ2 test.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.